You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Lungs in Vitro Market Size, Status and Forecast 2020-2026

Lungs in Vitro is applied for Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, and Regenerative Medicine. It include four types that are 2D Cell Models, 3D Cell Models, Commercial 3D Cell Models, and Inhouse 3D Cell Models
Market Analysis and Insights: Global Lungs in Vitro Market
The global Lungs in Vitro market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Lungs in Vitro Scope and Market Size
Lungs in Vitro market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lungs in Vitro market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
ATCC
Lonza
Epithelix
Mattek
Emulate
Mimetas
Tissuse
Insphero
Cn Bio
Lungs in Vitro Breakdown Data by Type
2D Cell Models
3D Cell Models
Commercial 3D Cell Models
Inhouse 3D Cell Models
Lungs in Vitro Breakdown Data by Application
Drug Screening
Toxicology
3D Model Development
Basic Research
Physiologic Research
Stem Cell Research
Regenerative Medicine
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lungs in Vitro Revenue
1.4 Market by Type
1.4.1 Global Lungs in Vitro Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 2D Cell Models
1.4.3 3D Cell Models
1.4.4 Commercial 3D Cell Models
1.4.5 Inhouse 3D Cell Models
1.5 Market by Application
1.5.1 Global Lungs in Vitro Market Share by Application: 2020 VS 2026
1.5.2 Drug Screening
1.5.3 Toxicology
1.5.4 3D Model Development
1.5.5 Basic Research
1.5.6 Physiologic Research
1.5.7 Stem Cell Research
1.5.8 Regenerative Medicine
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Lungs in Vitro Market Perspective (2015-2026)
2.2 Global Lungs in Vitro Growth Trends by Regions
2.2.1 Lungs in Vitro Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lungs in Vitro Historic Market Share by Regions (2015-2020)
2.2.3 Lungs in Vitro Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lungs in Vitro Market Growth Strategy
2.3.6 Primary Interviews with Key Lungs in Vitro Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Lungs in Vitro Players by Market Size
3.1.1 Global Top Lungs in Vitro Players by Revenue (2015-2020)
3.1.2 Global Lungs in Vitro Revenue Market Share by Players (2015-2020)
3.1.3 Global Lungs in Vitro Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lungs in Vitro Market Concentration Ratio
3.2.1 Global Lungs in Vitro Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lungs in Vitro Revenue in 2019
3.3 Lungs in Vitro Key Players Head office and Area Served
3.4 Key Players Lungs in Vitro Product Solution and Service
3.5 Date of Enter into Lungs in Vitro Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Lungs in Vitro Historic Market Size by Type (2015-2020)
4.2 Global Lungs in Vitro Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Lungs in Vitro Market Size by Application (2015-2020)
5.2 Global Lungs in Vitro Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Lungs in Vitro Market Size (2015-2020)
6.2 Lungs in Vitro Key Players in North America (2019-2020)
6.3 North America Lungs in Vitro Market Size by Type (2015-2020)
6.4 North America Lungs in Vitro Market Size by Application (2015-2020)

7 Europe
7.1 Europe Lungs in Vitro Market Size (2015-2020)
7.2 Lungs in Vitro Key Players in Europe (2019-2020)
7.3 Europe Lungs in Vitro Market Size by Type (2015-2020)
7.4 Europe Lungs in Vitro Market Size by Application (2015-2020)

8 China
8.1 China Lungs in Vitro Market Size (2015-2020)
8.2 Lungs in Vitro Key Players in China (2019-2020)
8.3 China Lungs in Vitro Market Size by Type (2015-2020)
8.4 China Lungs in Vitro Market Size by Application (2015-2020)

9 Japan
9.1 Japan Lungs in Vitro Market Size (2015-2020)
9.2 Lungs in Vitro Key Players in Japan (2019-2020)
9.3 Japan Lungs in Vitro Market Size by Type (2015-2020)
9.4 Japan Lungs in Vitro Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Lungs in Vitro Market Size (2015-2020)
10.2 Lungs in Vitro Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lungs in Vitro Market Size by Type (2015-2020)
10.4 Southeast Asia Lungs in Vitro Market Size by Application (2015-2020)

11 India
11.1 India Lungs in Vitro Market Size (2015-2020)
11.2 Lungs in Vitro Key Players in India (2019-2020)
11.3 India Lungs in Vitro Market Size by Type (2015-2020)
11.4 India Lungs in Vitro Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Lungs in Vitro Market Size (2015-2020)
12.2 Lungs in Vitro Key Players in Central & South America (2019-2020)
12.3 Central & South America Lungs in Vitro Market Size by Type (2015-2020)
12.4 Central & South America Lungs in Vitro Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 ATCC
13.1.1 ATCC Company Details
13.1.2 ATCC Business Overview
13.1.3 ATCC Lungs in Vitro Introduction
13.1.4 ATCC Revenue in Lungs in Vitro Business (2015-2020))
13.1.5 ATCC Recent Development
13.2 Lonza
13.2.1 Lonza Company Details
13.2.2 Lonza Business Overview
13.2.3 Lonza Lungs in Vitro Introduction
13.2.4 Lonza Revenue in Lungs in Vitro Business (2015-2020)
13.2.5 Lonza Recent Development
13.3 Epithelix
13.3.1 Epithelix Company Details
13.3.2 Epithelix Business Overview
13.3.3 Epithelix Lungs in Vitro Introduction
13.3.4 Epithelix Revenue in Lungs in Vitro Business (2015-2020)
13.3.5 Epithelix Recent Development
13.4 Mattek
13.4.1 Mattek Company Details
13.4.2 Mattek Business Overview
13.4.3 Mattek Lungs in Vitro Introduction
13.4.4 Mattek Revenue in Lungs in Vitro Business (2015-2020)
13.4.5 Mattek Recent Development
13.5 Emulate
13.5.1 Emulate Company Details
13.5.2 Emulate Business Overview
13.5.3 Emulate Lungs in Vitro Introduction
13.5.4 Emulate Revenue in Lungs in Vitro Business (2015-2020)
13.5.5 Emulate Recent Development
13.6 Mimetas
13.6.1 Mimetas Company Details
13.6.2 Mimetas Business Overview
13.6.3 Mimetas Lungs in Vitro Introduction
13.6.4 Mimetas Revenue in Lungs in Vitro Business (2015-2020)
13.6.5 Mimetas Recent Development
13.7 Tissuse
13.7.1 Tissuse Company Details
13.7.2 Tissuse Business Overview
13.7.3 Tissuse Lungs in Vitro Introduction
13.7.4 Tissuse Revenue in Lungs in Vitro Business (2015-2020)
13.7.5 Tissuse Recent Development
13.8 Insphero
13.8.1 Insphero Company Details
13.8.2 Insphero Business Overview
13.8.3 Insphero Lungs in Vitro Introduction
13.8.4 Insphero Revenue in Lungs in Vitro Business (2015-2020)
13.8.5 Insphero Recent Development
13.9 Cn Bio
13.9.1 Cn Bio Company Details
13.9.2 Cn Bio Business Overview
13.9.3 Cn Bio Lungs in Vitro Introduction
13.9.4 Cn Bio Revenue in Lungs in Vitro Business (2015-2020)
13.9.5 Cn Bio Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2020
  • NO OF PAGES: 134